Clinical trial
Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and…
NCT00189709 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00189709 |
|---|---|
| Title | Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia |
| Official title | A Single Center, Open, Parallel, Comparative, Randomized Study of Micafungin (FK463) vs Fluconazole (Diflucan) in the Treatment of Invasive Candidiasis and Candidaemia (Protocol No: MCFGCAN-0301F-TW) |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Collaborators | Astellas Pharma Taiwan, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Invasive Candidiasis, Candidemia |
| Intervention type | Drug |
| Interventions | Micafungin, fluconazole |
| Enrollment | 24 |
| Start date | Aug 1, 2004 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Jan 2, 2008 |
| Countries | Taiwan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: